Rare diseases
Investigational molecules
Locations
Back to Italy2 907 clinical trials in Legnano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
ItalyEfficacy and Safety Study of Paltusotine for Adults with Carcinoid Syndrome due to Well-Differentiated Neuroendocrine Tumors
ItalyStudy of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma
ItalyStudy on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults
ItalyStudy on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients
ItalyStudy on Rocatinlimab for Adolescents Aged 12-17 with Moderate-to-Severe Atopic Dermatitis
ItalyStudy of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults
ItalySaroglitazar hemimagnesium normalizes alkaline phosphatase in primary biliary cholangitis patients with incomplete response or intolerance to ursodeoxycholic acid
ItalyPhase 3 Study of trastuzumab brengitecan versus platinum‑based chemotherapy in adults with HER2‑positive metastatic urothelial cancer after anti‑PD‑(L)1 therapy
ItalyPhase 2 Study of Apitegromab in Patients with Facioscapulohumeral Muscular Dystrophy
ItalyEfficacy and Safety of Rezpegaldesleukin (NKTR-358) in Patients Aged 12 Years and Older with Moderate-to-Severe Atopic Dermatitis
ItalyEffect of Inclisiran, Ezetimibe and Statin Therapy on LDL‑C Levels in Patients with Chronic Coronary Syndrome or Prior Myocardial Infarction
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on Multiple Myeloma treatments, including innovative therapies for relapsed and refractory cases. Studies evaluating new drug combinations and treatment approaches for better patient outcomes.
Multiple ongoing trials testing various therapeutic combinations to improve survival rates.
Groundbreaking studies in lung cancer and breast cancer treatment, investigating novel immunotherapy combinations and targeted therapies.
Focus on personalized treatment approaches and biomarker-driven therapies.
Innovative research in chronic kidney disease and HIV management, exploring new treatment strategies and medication combinations.
Studies aimed at improving long-term patient outcomes and quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
